Trinity Biotech plc (ADR) (NASDAQ:TRIB)

CAPS Rating: 5 out of 5

The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

Recs

1
Player Avatar wracky (< 20) Submitted: 7/31/2008 10:03:21 PM : Underperform Start Price: $3.00 TRIB Score: -416.73

It's a BS company

Featured Broker Partners


Advertisement